Actinium Pharmaceuticals Inc (ATNM)
6.85
+0.18
(+2.70%)
USD |
NYAM |
Apr 19, 16:00
6.83
-0.02
(-0.29%)
After-Hours: 20:00
Actinium Pharmaceuticals Market Cap: 201.37M for April 19, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 19, 2024 | 201.37M |
| April 18, 2024 | 196.07M |
| April 17, 2024 | 213.12M |
| April 16, 2024 | 227.53M |
| April 15, 2024 | 248.11M |
| April 12, 2024 | 264.57M |
| April 11, 2024 | 267.21M |
| April 10, 2024 | 264.27M |
| April 09, 2024 | 263.98M |
| April 08, 2024 | 268.39M |
| April 05, 2024 | 280.44M |
| April 04, 2024 | 268.39M |
| April 03, 2024 | 259.86M |
| April 02, 2024 | 252.81M |
| April 01, 2024 | 251.63M |
| March 28, 2024 | 230.17M |
| March 27, 2024 | 233.41M |
| March 26, 2024 | 225.45M |
| March 25, 2024 | 240.72M |
| March 22, 2024 | 255.43M |
| March 21, 2024 | 252.93M |
| March 20, 2024 | 238.77M |
| March 19, 2024 | 227.94M |
| March 18, 2024 | 181.58M |
| March 15, 2024 | 187.41M |
| Date | Value |
|---|---|
| March 14, 2024 | 174.08M |
| March 13, 2024 | 186.02M |
| March 12, 2024 | 182.97M |
| March 11, 2024 | 192.13M |
| March 08, 2024 | 212.40M |
| March 07, 2024 | 211.29M |
| March 06, 2024 | 215.45M |
| March 05, 2024 | 215.73M |
| March 04, 2024 | 218.78M |
| March 01, 2024 | 235.16M |
| February 29, 2024 | 236.83M |
| February 28, 2024 | 230.72M |
| February 27, 2024 | 229.61M |
| February 26, 2024 | 230.72M |
| February 23, 2024 | 190.46M |
| February 22, 2024 | 187.13M |
| February 21, 2024 | 184.91M |
| February 20, 2024 | 192.68M |
| February 16, 2024 | 176.86M |
| February 15, 2024 | 163.25M |
| February 14, 2024 | 156.87M |
| February 13, 2024 | 148.54M |
| February 12, 2024 | 157.42M |
| February 09, 2024 | 151.59M |
| February 08, 2024 | 142.99M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
28.82M
Minimum
Mar 18 2020
366.12M
Maximum
Feb 16 2023
142.27M
Average
145.27M
Median
Aug 10 2021
Market Cap Benchmarks
| Perspective Therapeutics Inc | 880.37M |
| Eli Lilly and Co | 690.55B |
| Cellectar Biosciences Inc | 97.75M |
| Bristol-Myers Squibb Co | 98.95B |
| Oragenics Inc | 5.063M |
Market Cap Related Metrics
| PEG Ratio | -0.1115 |
| Price to Book Value | 5.535 |
| Price | 6.85 |
| Earnings Yield | -26.72% |
| PEGY Ratio | -0.1115 |